nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—Venous thrombosis—Carboplatin—esophageal cancer	0.0239	0.0675	CcSEcCtD
Aminophylline—Fluid overload—Carboplatin—esophageal cancer	0.0208	0.0586	CcSEcCtD
Aminophylline—Overdose—Capecitabine—esophageal cancer	0.0207	0.0582	CcSEcCtD
Aminophylline—Acute overdose—Capecitabine—esophageal cancer	0.0207	0.0582	CcSEcCtD
Aminophylline—Extravasation—Carboplatin—esophageal cancer	0.0148	0.0417	CcSEcCtD
Aminophylline—HDAC2—exocrine gland—esophageal cancer	0.014	0.118	CbGeAlD
Aminophylline—Diuresis—Cisplatin—esophageal cancer	0.0122	0.0345	CcSEcCtD
Aminophylline—Theophylline—PDE4D—esophageal cancer	0.0119	0.616	CrCbGaD
Aminophylline—Phlebitis—Carboplatin—esophageal cancer	0.0109	0.0307	CcSEcCtD
Aminophylline—Skin necrosis—Cisplatin—esophageal cancer	0.0109	0.0306	CcSEcCtD
Aminophylline—HDAC2—neck—esophageal cancer	0.00894	0.0756	CbGeAlD
Aminophylline—ADORA2B—bronchus—esophageal cancer	0.00844	0.0713	CbGeAlD
Aminophylline—ADORA2B—smooth muscle tissue—esophageal cancer	0.00826	0.0698	CbGeAlD
Aminophylline—Bronchial hyperreactivity—Methotrexate—esophageal cancer	0.00797	0.0225	CcSEcCtD
Aminophylline—ADORA2B—trachea—esophageal cancer	0.00758	0.0641	CbGeAlD
Aminophylline—Theophylline—CYP1B1—esophageal cancer	0.00739	0.384	CrCbGaD
Aminophylline—Chronic obstructive pulmonary disease—Methotrexate—esophageal cancer	0.00728	0.0205	CcSEcCtD
Aminophylline—Venous thrombosis—Cisplatin—esophageal cancer	0.00702	0.0198	CcSEcCtD
Aminophylline—Sinus tachycardia—Capecitabine—esophageal cancer	0.00694	0.0195	CcSEcCtD
Aminophylline—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.00652	0.0184	CcSEcCtD
Aminophylline—Fluid overload—Cisplatin—esophageal cancer	0.0061	0.0172	CcSEcCtD
Aminophylline—PDE3A—smooth muscle tissue—esophageal cancer	0.00609	0.0515	CbGeAlD
Aminophylline—HDAC2—epithelium—esophageal cancer	0.00608	0.0514	CbGeAlD
Aminophylline—HDAC2—bronchus—esophageal cancer	0.00599	0.0506	CbGeAlD
Aminophylline—Skin necrosis—Methotrexate—esophageal cancer	0.00595	0.0168	CcSEcCtD
Aminophylline—HDAC2—smooth muscle tissue—esophageal cancer	0.00586	0.0495	CbGeAlD
Aminophylline—ADORA2B—lung—esophageal cancer	0.00545	0.046	CbGeAlD
Aminophylline—Venous thrombosis—Capecitabine—esophageal cancer	0.00518	0.0146	CcSEcCtD
Aminophylline—PDE4A—lung—esophageal cancer	0.00485	0.041	CbGeAlD
Aminophylline—HDAC2—digestive system—esophageal cancer	0.00463	0.0391	CbGeAlD
Aminophylline—Infection—Carboplatin—esophageal cancer	0.00458	0.0129	CcSEcCtD
Aminophylline—Extravasation—Cisplatin—esophageal cancer	0.00435	0.0122	CcSEcCtD
Aminophylline—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.00427	0.012	CcSEcCtD
Aminophylline—Hyperuricaemia—Cisplatin—esophageal cancer	0.00409	0.0115	CcSEcCtD
Aminophylline—Haematemesis—Capecitabine—esophageal cancer	0.00402	0.0113	CcSEcCtD
Aminophylline—Hypercalcaemia—Capecitabine—esophageal cancer	0.00402	0.0113	CcSEcCtD
Aminophylline—PDE3A—lung—esophageal cancer	0.00401	0.0339	CbGeAlD
Aminophylline—ADORA1—lung—esophageal cancer	0.00391	0.0331	CbGeAlD
Aminophylline—HDAC2—lung—esophageal cancer	0.00386	0.0327	CbGeAlD
Aminophylline—Blood uric acid increased—Cisplatin—esophageal cancer	0.00386	0.0109	CcSEcCtD
Aminophylline—Body temperature increased—Carboplatin—esophageal cancer	0.00365	0.0103	CcSEcCtD
Aminophylline—Skin exfoliation—Cisplatin—esophageal cancer	0.00362	0.0102	CcSEcCtD
Aminophylline—Extrasystoles—Capecitabine—esophageal cancer	0.00332	0.00936	CcSEcCtD
Aminophylline—PDE4A—lymph node—esophageal cancer	0.00332	0.0281	CbGeAlD
Aminophylline—Phlebitis—Cisplatin—esophageal cancer	0.00319	0.009	CcSEcCtD
Aminophylline—Polyuria—Cisplatin—esophageal cancer	0.00313	0.00883	CcSEcCtD
Aminophylline—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00309	0.00872	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00309	0.00872	CcSEcCtD
Aminophylline—Haematemesis—Methotrexate—esophageal cancer	0.00299	0.00844	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00284	0.00801	CcSEcCtD
Aminophylline—PDE3A—lymph node—esophageal cancer	0.00275	0.0232	CbGeAlD
Aminophylline—ADORA1—lymph node—esophageal cancer	0.00268	0.0226	CbGeAlD
Aminophylline—Skin exfoliation—Capecitabine—esophageal cancer	0.00267	0.00752	CcSEcCtD
Aminophylline—HDAC2—lymph node—esophageal cancer	0.00264	0.0223	CbGeAlD
Aminophylline—Irritability—Cisplatin—esophageal cancer	0.00263	0.0074	CcSEcCtD
Aminophylline—Hypokalaemia—Cisplatin—esophageal cancer	0.0025	0.00706	CcSEcCtD
Aminophylline—Extravasation—Methotrexate—esophageal cancer	0.00238	0.00672	CcSEcCtD
Aminophylline—Phlebitis—Capecitabine—esophageal cancer	0.00235	0.00663	CcSEcCtD
Aminophylline—Polyuria—Capecitabine—esophageal cancer	0.00231	0.00651	CcSEcCtD
Aminophylline—Hyperuricaemia—Methotrexate—esophageal cancer	0.00224	0.00632	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00215	0.00606	CcSEcCtD
Aminophylline—Atrial fibrillation—Capecitabine—esophageal cancer	0.00214	0.00603	CcSEcCtD
Aminophylline—CYP1A2—digestive system—esophageal cancer	0.00213	0.018	CbGeAlD
Aminophylline—Blood uric acid increased—Methotrexate—esophageal cancer	0.00212	0.00597	CcSEcCtD
Aminophylline—Skin exfoliation—Methotrexate—esophageal cancer	0.00199	0.0056	CcSEcCtD
Aminophylline—Irritability—Capecitabine—esophageal cancer	0.00194	0.00546	CcSEcCtD
Aminophylline—Urinary retention—Capecitabine—esophageal cancer	0.00193	0.00543	CcSEcCtD
Aminophylline—CYP2E1—digestive system—esophageal cancer	0.00191	0.0162	CbGeAlD
Aminophylline—Coma—Methotrexate—esophageal cancer	0.0019	0.00536	CcSEcCtD
Aminophylline—Abdominal pain upper—Capecitabine—esophageal cancer	0.00185	0.00522	CcSEcCtD
Aminophylline—Hypokalaemia—Capecitabine—esophageal cancer	0.00185	0.0052	CcSEcCtD
Aminophylline—CYP1A2—lung—esophageal cancer	0.00178	0.015	CbGeAlD
Aminophylline—Flushing—Cisplatin—esophageal cancer	0.00177	0.00498	CcSEcCtD
Aminophylline—Polyuria—Methotrexate—esophageal cancer	0.00172	0.00485	CcSEcCtD
Aminophylline—Arrhythmia—Cisplatin—esophageal cancer	0.0017	0.00479	CcSEcCtD
Aminophylline—Alopecia—Cisplatin—esophageal cancer	0.00168	0.00474	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.0016	0.00451	CcSEcCtD
Aminophylline—CYP2E1—lung—esophageal cancer	0.0016	0.0135	CbGeAlD
Aminophylline—Hyperglycaemia—Capecitabine—esophageal cancer	0.00158	0.00446	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00156	0.0044	CcSEcCtD
Aminophylline—Tremor—Cisplatin—esophageal cancer	0.00155	0.00437	CcSEcCtD
Aminophylline—CYP3A4—digestive system—esophageal cancer	0.00154	0.013	CbGeAlD
Aminophylline—Haematuria—Capecitabine—esophageal cancer	0.00149	0.0042	CcSEcCtD
Aminophylline—Irritability—Methotrexate—esophageal cancer	0.00144	0.00406	CcSEcCtD
Aminophylline—Convulsion—Cisplatin—esophageal cancer	0.00144	0.00405	CcSEcCtD
Aminophylline—Anxiety—Cisplatin—esophageal cancer	0.00141	0.00396	CcSEcCtD
Aminophylline—Anaphylactic shock—Cisplatin—esophageal cancer	0.00135	0.00381	CcSEcCtD
Aminophylline—Infection—Cisplatin—esophageal cancer	0.00134	0.00379	CcSEcCtD
Aminophylline—Nervous system disorder—Cisplatin—esophageal cancer	0.00133	0.00374	CcSEcCtD
Aminophylline—Tachycardia—Cisplatin—esophageal cancer	0.00132	0.00372	CcSEcCtD
Aminophylline—Flushing—Capecitabine—esophageal cancer	0.0013	0.00367	CcSEcCtD
Aminophylline—Anorexia—Cisplatin—esophageal cancer	0.00129	0.00363	CcSEcCtD
Aminophylline—Hypotension—Cisplatin—esophageal cancer	0.00126	0.00356	CcSEcCtD
Aminophylline—Arrhythmia—Capecitabine—esophageal cancer	0.00125	0.00353	CcSEcCtD
Aminophylline—Alopecia—Capecitabine—esophageal cancer	0.00124	0.00349	CcSEcCtD
Aminophylline—Decreased appetite—Cisplatin—esophageal cancer	0.00118	0.00331	CcSEcCtD
Aminophylline—Tremor—Capecitabine—esophageal cancer	0.00114	0.00322	CcSEcCtD
Aminophylline—Haematuria—Methotrexate—esophageal cancer	0.00111	0.00313	CcSEcCtD
Aminophylline—Palpitations—Capecitabine—esophageal cancer	0.00108	0.00304	CcSEcCtD
Aminophylline—Body temperature increased—Cisplatin—esophageal cancer	0.00107	0.00301	CcSEcCtD
Aminophylline—Anxiety—Capecitabine—esophageal cancer	0.00104	0.00292	CcSEcCtD
Aminophylline—Hypersensitivity—Cisplatin—esophageal cancer	0.000997	0.00281	CcSEcCtD
Aminophylline—Infection—Capecitabine—esophageal cancer	0.000991	0.00279	CcSEcCtD
Aminophylline—Shock—Capecitabine—esophageal cancer	0.000981	0.00276	CcSEcCtD
Aminophylline—Nervous system disorder—Capecitabine—esophageal cancer	0.000978	0.00275	CcSEcCtD
Aminophylline—Tachycardia—Capecitabine—esophageal cancer	0.000973	0.00274	CcSEcCtD
Aminophylline—Anorexia—Capecitabine—esophageal cancer	0.000951	0.00268	CcSEcCtD
Aminophylline—Hypotension—Capecitabine—esophageal cancer	0.000932	0.00262	CcSEcCtD
Aminophylline—Diarrhoea—Cisplatin—esophageal cancer	0.000926	0.00261	CcSEcCtD
Aminophylline—Alopecia—Methotrexate—esophageal cancer	0.000923	0.0026	CcSEcCtD
Aminophylline—Insomnia—Capecitabine—esophageal cancer	0.000902	0.00254	CcSEcCtD
Aminophylline—Dyspepsia—Capecitabine—esophageal cancer	0.000878	0.00247	CcSEcCtD
Aminophylline—Decreased appetite—Capecitabine—esophageal cancer	0.000867	0.00244	CcSEcCtD
Aminophylline—Vomiting—Cisplatin—esophageal cancer	0.00086	0.00242	CcSEcCtD
Aminophylline—Rash—Cisplatin—esophageal cancer	0.000853	0.0024	CcSEcCtD
Aminophylline—Dermatitis—Cisplatin—esophageal cancer	0.000852	0.0024	CcSEcCtD
Aminophylline—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000815	0.0023	CcSEcCtD
Aminophylline—Nausea—Cisplatin—esophageal cancer	0.000804	0.00226	CcSEcCtD
Aminophylline—Urticaria—Capecitabine—esophageal cancer	0.000792	0.00223	CcSEcCtD
Aminophylline—Body temperature increased—Capecitabine—esophageal cancer	0.000788	0.00222	CcSEcCtD
Aminophylline—Abdominal pain—Capecitabine—esophageal cancer	0.000788	0.00222	CcSEcCtD
Aminophylline—Convulsion—Methotrexate—esophageal cancer	0.000788	0.00222	CcSEcCtD
Aminophylline—Anaphylactic shock—Methotrexate—esophageal cancer	0.000742	0.00209	CcSEcCtD
Aminophylline—Infection—Methotrexate—esophageal cancer	0.000737	0.00208	CcSEcCtD
Aminophylline—Hypersensitivity—Capecitabine—esophageal cancer	0.000735	0.00207	CcSEcCtD
Aminophylline—Nervous system disorder—Methotrexate—esophageal cancer	0.000728	0.00205	CcSEcCtD
Aminophylline—Anorexia—Methotrexate—esophageal cancer	0.000708	0.00199	CcSEcCtD
Aminophylline—Pruritus—Capecitabine—esophageal cancer	0.000705	0.00199	CcSEcCtD
Aminophylline—Hypotension—Methotrexate—esophageal cancer	0.000694	0.00195	CcSEcCtD
Aminophylline—Diarrhoea—Capecitabine—esophageal cancer	0.000682	0.00192	CcSEcCtD
Aminophylline—Insomnia—Methotrexate—esophageal cancer	0.000671	0.00189	CcSEcCtD
Aminophylline—Dizziness—Capecitabine—esophageal cancer	0.000659	0.00186	CcSEcCtD
Aminophylline—Dyspepsia—Methotrexate—esophageal cancer	0.000653	0.00184	CcSEcCtD
Aminophylline—Decreased appetite—Methotrexate—esophageal cancer	0.000645	0.00182	CcSEcCtD
Aminophylline—Vomiting—Capecitabine—esophageal cancer	0.000634	0.00179	CcSEcCtD
Aminophylline—Rash—Capecitabine—esophageal cancer	0.000629	0.00177	CcSEcCtD
Aminophylline—Dermatitis—Capecitabine—esophageal cancer	0.000628	0.00177	CcSEcCtD
Aminophylline—Headache—Capecitabine—esophageal cancer	0.000625	0.00176	CcSEcCtD
Aminophylline—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000607	0.00171	CcSEcCtD
Aminophylline—Nausea—Capecitabine—esophageal cancer	0.000592	0.00167	CcSEcCtD
Aminophylline—Urticaria—Methotrexate—esophageal cancer	0.00059	0.00166	CcSEcCtD
Aminophylline—Abdominal pain—Methotrexate—esophageal cancer	0.000587	0.00165	CcSEcCtD
Aminophylline—Body temperature increased—Methotrexate—esophageal cancer	0.000587	0.00165	CcSEcCtD
Aminophylline—Hypersensitivity—Methotrexate—esophageal cancer	0.000547	0.00154	CcSEcCtD
Aminophylline—Pruritus—Methotrexate—esophageal cancer	0.000525	0.00148	CcSEcCtD
Aminophylline—Diarrhoea—Methotrexate—esophageal cancer	0.000508	0.00143	CcSEcCtD
Aminophylline—Dizziness—Methotrexate—esophageal cancer	0.000491	0.00138	CcSEcCtD
Aminophylline—Vomiting—Methotrexate—esophageal cancer	0.000472	0.00133	CcSEcCtD
Aminophylline—Rash—Methotrexate—esophageal cancer	0.000468	0.00132	CcSEcCtD
Aminophylline—Dermatitis—Methotrexate—esophageal cancer	0.000468	0.00132	CcSEcCtD
Aminophylline—Headache—Methotrexate—esophageal cancer	0.000465	0.00131	CcSEcCtD
Aminophylline—Nausea—Methotrexate—esophageal cancer	0.000441	0.00124	CcSEcCtD
Aminophylline—PDE3A—Signaling Pathways—NOTCH2—esophageal cancer	0.000119	0.000234	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—PIK3CA—esophageal cancer	0.000116	0.000229	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NOTCH2—esophageal cancer	0.000114	0.000225	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CA2—esophageal cancer	0.000114	0.000225	CbGpPWpGaD
Aminophylline—HDAC2—Disease—SMAD4—esophageal cancer	0.000114	0.000224	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000114	0.000224	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000113	0.000223	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000112	0.000221	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PSME2—esophageal cancer	0.000112	0.000221	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PSME1—esophageal cancer	0.000112	0.000221	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—ANXA1—esophageal cancer	0.000112	0.00022	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CXCL2—esophageal cancer	0.000112	0.00022	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SST—esophageal cancer	0.000109	0.000214	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TGFBR2—esophageal cancer	0.000108	0.000213	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—EP300—esophageal cancer	0.000107	0.000211	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PLCE1—esophageal cancer	0.000106	0.000209	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ADH7—esophageal cancer	0.000106	0.000209	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NOTCH3—esophageal cancer	0.000106	0.000209	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—GHRL—esophageal cancer	0.000106	0.000209	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TGFBR2—esophageal cancer	0.000105	0.000208	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PSME2—esophageal cancer	0.000104	0.000206	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PSME1—esophageal cancer	0.000104	0.000206	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—FBXW7—esophageal cancer	0.000104	0.000205	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—ANXA1—esophageal cancer	0.000104	0.000205	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SMAD4—esophageal cancer	0.000103	0.000202	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TGFBR2—esophageal cancer	0.000101	0.0002	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SST—esophageal cancer	0.000101	0.000199	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SMAD4—esophageal cancer	9.98e-05	0.000197	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	9.93e-05	0.000196	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—PIK3CA—esophageal cancer	9.91e-05	0.000195	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NOTCH3—esophageal cancer	9.84e-05	0.000194	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—GHRL—esophageal cancer	9.84e-05	0.000194	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—FBXW7—esophageal cancer	9.68e-05	0.000191	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SMAD4—esophageal cancer	9.6e-05	0.000189	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—TP53—esophageal cancer	9.58e-05	0.000189	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NOTCH2—esophageal cancer	9.5e-05	0.000187	CbGpPWpGaD
Aminophylline—HDAC2—Disease—HIF1A—esophageal cancer	9.32e-05	0.000184	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ADH1B—esophageal cancer	9.31e-05	0.000183	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—HIF1A—esophageal cancer	9.24e-05	0.000182	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—NOTCH1—esophageal cancer	9.04e-05	0.000178	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—TYMP—esophageal cancer	8.9e-05	0.000175	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KDR—esophageal cancer	8.84e-05	0.000174	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NOTCH2—esophageal cancer	8.83e-05	0.000174	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—BLVRB—esophageal cancer	8.83e-05	0.000174	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC52A3—esophageal cancer	8.83e-05	0.000174	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP26A1—esophageal cancer	8.65e-05	0.000171	CbGpPWpGaD
Aminophylline—HDAC2—Disease—NOS2—esophageal cancer	8.48e-05	0.000167	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ALOX15—esophageal cancer	8.43e-05	0.000166	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TGFBR2—esophageal cancer	8.42e-05	0.000166	CbGpPWpGaD
Aminophylline—HDAC2—Disease—NOTCH1—esophageal cancer	8.39e-05	0.000165	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—HIF1A—esophageal cancer	8.39e-05	0.000165	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NOTCH1—esophageal cancer	8.32e-05	0.000164	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—CREBBP—esophageal cancer	8.2e-05	0.000162	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—HIF1A—esophageal cancer	8.16e-05	0.000161	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTO1—esophageal cancer	8.05e-05	0.000159	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—TPI1—esophageal cancer	8.05e-05	0.000159	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KDR—esophageal cancer	8.02e-05	0.000158	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SMAD4—esophageal cancer	7.97e-05	0.000157	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—PIK3CA—esophageal cancer	7.92e-05	0.000156	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.89e-05	0.000156	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—HIF1A—esophageal cancer	7.86e-05	0.000155	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TGFBR2—esophageal cancer	7.83e-05	0.000154	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KDR—esophageal cancer	7.81e-05	0.000154	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ALDOB—esophageal cancer	7.71e-05	0.000152	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—TP53—esophageal cancer	7.66e-05	0.000151	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CREBBP—esophageal cancer	7.61e-05	0.00015	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NOTCH1—esophageal cancer	7.56e-05	0.000149	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CREBBP—esophageal cancer	7.55e-05	0.000149	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KDR—esophageal cancer	7.51e-05	0.000148	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CA1—esophageal cancer	7.51e-05	0.000148	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC10A2—esophageal cancer	7.51e-05	0.000148	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GAPDH—esophageal cancer	7.43e-05	0.000146	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—EGFR—esophageal cancer	7.42e-05	0.000146	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SMAD4—esophageal cancer	7.41e-05	0.000146	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CRABP1—esophageal cancer	7.36e-05	0.000145	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NOTCH1—esophageal cancer	7.35e-05	0.000145	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	7.09e-05	0.00014	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NOTCH1—esophageal cancer	7.08e-05	0.000139	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GNG7—esophageal cancer	7e-05	0.000138	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CA2—esophageal cancer	6.87e-05	0.000135	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CREBBP—esophageal cancer	6.85e-05	0.000135	CbGpPWpGaD
Aminophylline—HDAC2—Disease—NOS3—esophageal cancer	6.81e-05	0.000134	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—BLVRB—esophageal cancer	6.81e-05	0.000134	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC52A3—esophageal cancer	6.81e-05	0.000134	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NOS3—esophageal cancer	6.76e-05	0.000133	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—EGFR—esophageal cancer	6.73e-05	0.000133	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.71e-05	0.000132	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CREBBP—esophageal cancer	6.67e-05	0.000131	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ALDH2—esophageal cancer	6.56e-05	0.000129	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—EGFR—esophageal cancer	6.55e-05	0.000129	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—HIF1A—esophageal cancer	6.53e-05	0.000129	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—PIK3CA—esophageal cancer	6.44e-05	0.000127	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.44e-05	0.000127	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CREBBP—esophageal cancer	6.42e-05	0.000126	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PLCE1—esophageal cancer	6.38e-05	0.000126	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ADH7—esophageal cancer	6.38e-05	0.000126	CbGpPWpGaD
Aminophylline—HDAC2—Disease—ERBB2—esophageal cancer	6.37e-05	0.000126	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—ERBB2—esophageal cancer	6.32e-05	0.000125	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.31e-05	0.000124	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—EGFR—esophageal cancer	6.31e-05	0.000124	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.26e-05	0.000123	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KDR—esophageal cancer	6.24e-05	0.000123	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTT1—esophageal cancer	6.24e-05	0.000123	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTGS2—esophageal cancer	6.23e-05	0.000123	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP2A6—esophageal cancer	6.17e-05	0.000122	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NOS3—esophageal cancer	6.14e-05	0.000121	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HIF1A—esophageal cancer	6.07e-05	0.00012	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—PIK3CA—esophageal cancer	6.03e-05	0.000119	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NOS3—esophageal cancer	5.97e-05	0.000118	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NOTCH1—esophageal cancer	5.88e-05	0.000116	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS1—esophageal cancer	5.85e-05	0.000115	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ENO1—esophageal cancer	5.85e-05	0.000115	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—PIK3CA—esophageal cancer	5.85e-05	0.000115	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KDR—esophageal cancer	5.8e-05	0.000114	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CA1—esophageal cancer	5.79e-05	0.000114	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC10A2—esophageal cancer	5.79e-05	0.000114	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PSME2—esophageal cancer	5.76e-05	0.000114	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PSME1—esophageal cancer	5.76e-05	0.000114	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NOS3—esophageal cancer	5.75e-05	0.000113	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—ERBB2—esophageal cancer	5.74e-05	0.000113	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—PIK3CA—esophageal cancer	5.69e-05	0.000112	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ADH1B—esophageal cancer	5.6e-05	0.00011	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCND1—esophageal cancer	5.58e-05	0.00011	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—ERBB2—esophageal cancer	5.58e-05	0.00011	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—PIK3CA—esophageal cancer	5.47e-05	0.000108	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NOTCH1—esophageal cancer	5.47e-05	0.000108	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CDKN1A—esophageal cancer	5.45e-05	0.000107	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CDKN1A—esophageal cancer	5.4e-05	0.000106	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—ERBB2—esophageal cancer	5.37e-05	0.000106	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TYMP—esophageal cancer	5.35e-05	0.000105	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CREBBP—esophageal cancer	5.33e-05	0.000105	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CA2—esophageal cancer	5.3e-05	0.000104	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP26A1—esophageal cancer	5.2e-05	0.000103	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EP300—esophageal cancer	5.18e-05	0.000102	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EP300—esophageal cancer	5.14e-05	0.000101	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCND1—esophageal cancer	5.07e-05	9.99e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALOX15—esophageal cancer	5.07e-05	9.99e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP1B1—esophageal cancer	4.97e-05	9.8e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CREBBP—esophageal cancer	4.96e-05	9.76e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCND1—esophageal cancer	4.93e-05	9.72e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ADH7—esophageal cancer	4.93e-05	9.71e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PLCE1—esophageal cancer	4.93e-05	9.71e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CDKN1A—esophageal cancer	4.91e-05	9.67e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—EGFR—esophageal cancer	4.87e-05	9.6e-05	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—MYC—esophageal cancer	4.87e-05	9.59e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTO1—esophageal cancer	4.84e-05	9.53e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TPI1—esophageal cancer	4.84e-05	9.53e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CDKN1A—esophageal cancer	4.77e-05	9.4e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NOS3—esophageal cancer	4.77e-05	9.4e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCND1—esophageal cancer	4.75e-05	9.36e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP19A1—esophageal cancer	4.67e-05	9.21e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EP300—esophageal cancer	4.67e-05	9.2e-05	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	4.65e-05	9.17e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALDOB—esophageal cancer	4.64e-05	9.14e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CDKN1A—esophageal cancer	4.59e-05	9.05e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EP300—esophageal cancer	4.54e-05	8.95e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MYC—esophageal cancer	4.52e-05	8.9e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MYC—esophageal cancer	4.48e-05	8.83e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GAPDH—esophageal cancer	4.46e-05	8.8e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—ERBB2—esophageal cancer	4.46e-05	8.8e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NOS3—esophageal cancer	4.44e-05	8.74e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CRABP1—esophageal cancer	4.42e-05	8.72e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EGFR—esophageal cancer	4.42e-05	8.71e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EGFR—esophageal cancer	4.38e-05	8.63e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EP300—esophageal cancer	4.37e-05	8.61e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.32e-05	8.51e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—HMOX1—esophageal cancer	4.26e-05	8.4e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PIK3CA—esophageal cancer	4.23e-05	8.33e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GNG7—esophageal cancer	4.21e-05	8.29e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—ERBB2—esophageal cancer	4.15e-05	8.18e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TYMP—esophageal cancer	4.13e-05	8.13e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ABCB1—esophageal cancer	4.09e-05	8.07e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MYC—esophageal cancer	4.07e-05	8.02e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.02e-05	7.91e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EGFR—esophageal cancer	3.98e-05	7.84e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MYC—esophageal cancer	3.96e-05	7.8e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCND1—esophageal cancer	3.94e-05	7.77e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALDH2—esophageal cancer	3.94e-05	7.77e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALOX15—esophageal cancer	3.91e-05	7.71e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EGFR—esophageal cancer	3.87e-05	7.63e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PIK3CA—esophageal cancer	3.83e-05	7.56e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CDKN1A—esophageal cancer	3.82e-05	7.52e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MYC—esophageal cancer	3.81e-05	7.51e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PIK3CA—esophageal cancer	3.8e-05	7.49e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTT1—esophageal cancer	3.75e-05	7.39e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.73e-05	7.36e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TPI1—esophageal cancer	3.73e-05	7.36e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EGFR—esophageal cancer	3.73e-05	7.34e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP2A6—esophageal cancer	3.71e-05	7.31e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.69e-05	7.28e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—esophageal cancer	3.68e-05	7.25e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCND1—esophageal cancer	3.67e-05	7.22e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EP300—esophageal cancer	3.63e-05	7.15e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.58e-05	7.05e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CDKN1A—esophageal cancer	3.55e-05	6.99e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ENO1—esophageal cancer	3.51e-05	6.93e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS1—esophageal cancer	3.51e-05	6.93e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PSME2—esophageal cancer	3.46e-05	6.82e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PSME1—esophageal cancer	3.46e-05	6.82e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PIK3CA—esophageal cancer	3.45e-05	6.8e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.45e-05	6.79e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.41e-05	6.73e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EP300—esophageal cancer	3.37e-05	6.65e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PIK3CA—esophageal cancer	3.36e-05	6.62e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—esophageal cancer	3.34e-05	6.58e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—esophageal cancer	3.25e-05	6.4e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GNG7—esophageal cancer	3.25e-05	6.4e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PIK3CA—esophageal cancer	3.23e-05	6.37e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MYC—esophageal cancer	3.16e-05	6.23e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—esophageal cancer	3.13e-05	6.16e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EGFR—esophageal cancer	3.09e-05	6.1e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.04e-05	6e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.02e-05	5.96e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.99e-05	5.89e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MYC—esophageal cancer	2.94e-05	5.8e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.89e-05	5.7e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EGFR—esophageal cancer	2.88e-05	5.67e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.86e-05	5.64e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.81e-05	5.54e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CREBBP—esophageal cancer	2.74e-05	5.39e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ENO1—esophageal cancer	2.71e-05	5.35e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.71e-05	5.35e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CA—esophageal cancer	2.69e-05	5.29e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PSME2—esophageal cancer	2.67e-05	5.27e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PSME1—esophageal cancer	2.67e-05	5.27e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—esophageal cancer	2.6e-05	5.12e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HMOX1—esophageal cancer	2.56e-05	5.05e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.52e-05	4.96e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CA—esophageal cancer	2.5e-05	4.92e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCB1—esophageal cancer	2.46e-05	4.85e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NOS3—esophageal cancer	2.45e-05	4.83e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—esophageal cancer	2.42e-05	4.76e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.31e-05	4.54e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—esophageal cancer	2.24e-05	4.41e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.17e-05	4.27e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.98e-05	3.9e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.9e-05	3.74e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—EP300—esophageal cancer	1.86e-05	3.67e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.86e-05	3.67e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.64e-05	3.24e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NOS3—esophageal cancer	1.47e-05	2.9e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CA—esophageal cancer	1.38e-05	2.72e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.35e-05	2.65e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.27e-05	2.5e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NOS3—esophageal cancer	1.14e-05	2.24e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—EP300—esophageal cancer	1.12e-05	2.21e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.04e-05	2.05e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—EP300—esophageal cancer	8.64e-06	1.7e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CA—esophageal cancer	8.29e-06	1.63e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CA—esophageal cancer	6.39e-06	1.26e-05	CbGpPWpGaD
